Objective Acute pancreatitis is caused by toxins that induce acinar cell calcium overload, zymogen activation, cytokine release and cell death, yet is without specific drug therapy. Mitochondrial dysfunction has been implicated but the mechanism not established.
Design We investigated the mechanism of induction and consequences of the mitochondrial permeability transition pore (MPTP) in the pancreas using cell biological methods including confocal microscopy, patch clamp technology and multiple clinically representative disease models. Effects of genetic and pharmacological inhibition of the MPTP were examined in isolated murine and human pancreatic acinar cells, and in hyperstimulation, bile acid, alcoholic and choline-deficient, ethionine-supplemented acute pancreatitis.
Results MPTP opening was mediated by toxin-induced inositol trisphosphate and ryanodine receptor calcium channel release, and resulted in diminished ATP production, leading to impaired calcium clearance, defective autophagy, zymogen activation, cytokine production, phosphoglycerate mutase 5 activation and necrosis, which was prevented by intracellular ATP supplementation. When MPTP opening was inhibited genetically or pharmacologically, all biochemical, immunological and histopathological responses of acute pancreatitis in all four models were reduced or abolished.
Conclusions This work demonstrates the mechanism and consequences of MPTP opening to be fundamental to multiple forms of acute pancreatitis and validates the MPTP as a drug target for this disease.
- ACUTE PANCREATITIS
- CELL SIGNALLING
- CELL DEATH
This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Significance of this study
What is already known on this subject?
Toxins that induce acute pancreatitis cause pancreatic acinar cell calcium overload, intracellular zymogen activation, cytokine release and cell death.
Mitochondrial matrix calcium overload induces opening of the mitochondrial permeability transition pore (MPTP), a non-specific inner mitochondrial membrane channel that causes loss of mitochondrial membrane potential essential to ATP production.
Calcium-induced opening of the MPTP occurs in acute pancreatitis, but the mechanism and consequences of this process have not been established.
What are the new findings?
Toxins that cause acute pancreatitis induce the MPTP in isolated murine and human pancreatic acinar cells via second messenger receptor calcium channel release and mitochondrial calcium but not reactive oxygen species overload, resulting in mitochondrial depolarisation, impaired ATP production and necrosis.
Pancreatitis toxin-induced MPTP opening causes activation of phosphoglycerate mutase 5, which executes necrosis, and retarded autophagy, which causes accumulation of activated digestive enzymes.
Specific genetic or pharmacological inhibition of MPTP opening in a diverse range of clinically relevant mouse models dramatically improves all local pancreatic, systemic and distant pulmonary pathological responses.
How might it impact on clinical practice in the foreseeable future?
The demonstration of identical mechanisms in human as in murine pancreatic acinar cells indicates that the findings that establish MPTP opening to be of critical importance in experimental acute pancreatitis are likely to be of major importance in clinical acute pancreatitis.
This study has shown the effectiveness in experimental acute pancreatitis of several drugs that target molecules that regulate the MPTP and that could be developed for the treatment of clinical acute pancreatitis.
Translational drug discovery and development programmes that target the MPTP could provide specific, effective treatments for clinical acute pancreatitis.
Pancreatic necrosis, systemic inflammatory response syndrome, multiple organ failure and sepsis are characteristic of severe acute pancreatitis (AP), which results in death of one in four patients and is without specific drug therapy.1 ,2 As the pancreatic acinar cell is an initial site of injury,1 ,3 commonly initiated by bile or ethanol excess, investigation of its behaviour in response to toxins that induce AP may identify new drug targets. This cell typifies non-excitable exocrine cells with a high secretory turnover heavily dependent on mitochondrial production of ATP.4 While zymogen activation has long been considered the principal mechanism of injury,1 ,3 mitochondrial dysfunction has been implicated increasingly,5–11 presumed consequent upon intracellular calcium overload induced by toxins that include bile acids and ethanol metabolites.6 ,11 ,12 Mitochondrial uptake of calcium drives normal cellular bioenergetics, but high calcium loads induce increasingly drastic responses culminating in necrosis.13 Mitochondrial matrix calcium overload leads to opening of the mitochondrial permeability transition pore (MPTP), a non-specific channel that forms in the inner mitochondrial membrane allowing passage of particles under 1500 Da, causing loss of mitochondrial membrane potential (Δψm) essential to ATP production;13 recent evidence implicates F0F1 ATP synthase in MPTP formation.14 ,15 MPTP opening is physiological in low conductance mode releasing calcium and reactive oxygen species (ROS) to match metabolism with workload,16 but pathological in high conductance mode compromising ATP production and inducing cell death;13 both functions are regulated by the mitochondrial matrix protein peptidyl-prolyl cis-trans isomerase (PPI, cyclophilin) D (also known as cyclophilin F).17
Previous limited studies found that MPTP opening can occur in pancreatitis;5 ,9 ,18 we found cyclophilin D knockout to ameliorate AP induced by ethanol and cyclosporine,9 but in a model with no clinical correlate. How the MPTP is induced in pancreatic acinar cells has not been determined, nor what role intracellular calcium might play and whether there are downstream consequences in AP. Therefore, we sought to undertake a novel, wide ranging and detailed study to determine the mechanism and significance of MPTP opening in AP.
We report that MPTP opening is critical to all forms of pancreatitis investigated, causing diminished ATP production, defective autophagy, zymogen activation, cytokine release, phosphoglycerate mutase family member 5 (PGAM5) activation19 and necrosis. Pharmacological or genetic MPTP inhibition in murine or human pancreatic acinar cells protected Δψm, ATP production, autophagy and prevented necrosis from pancreatitis toxin-induced calcium release via inositol trisphosphate and ryanodine (IP3R, RyR) calcium channels. This mechanism was confirmed consistently across four dissimilar, clinically relevant, in vivo models of AP. All characteristic local and systemic pathological responses were greatly reduced or abolished in cyclophilin D knockout mice (Ppif−/−)20 and wild type (Wt) mice treated with MPTP inhibitors, confirming that MPTP opening is a fundamental pathological mechanism in AP.
Cyclophilin D-deficient mice were generated by targeted disruption of the Ppif gene20 and provided by Dr Derek Yellon (University College London, UK) and Dr Michael A Forte (Oregon Health and Sciences University, USA). Transgenic green fluorescent protein (GFP)-LC3 mice21 were a gift from Dr N Mizushima (Tokyo Medical and Dental University and RIKEN BioResourse Center, Japan). All experiments comparing Wt and Ppif−/− were conducted using C57BL/6 mice; experiments using toxins on Wt cells alone used CD1 mice.
Preparation of isolated pancreatic acinar cells and mitochondria
Normal human pancreata samples (∼1 cm×1 cm×1 mm, not devascularised during surgery before removal) were placed in a solution of (mM): 140 NaCl, 4.7 KCl, 1.13 MgCl2, 1 CaCl2, 10 D-glucose, 10 HEPES (adjusted to pH 7.35 using NaOH) at 4°C; sampling to start of cell isolation (or slicing below) was <10 min in every case. All experiments were at room temperature (23–25°C, except where stated) and cells used within 4 h of isolation. Isolation of murine7 and human22 pancreatic acinar cells was as described. Isolated murine cells were incubated at 37°C in 199 medium with or without 10 nM cholecystokinin-8 (CCK-8) or 500 µM taurolithocholic acid sulfate (TLCS); drug pretreatment was applied for 30 min. Mitochondria were isolated from mouse pancreata as described.23
Confocal fluorescence microscopy
Cells and tissue were viewed using Zeiss LSM510 and LSM710 systems (Carl Zeiss Jena GmbH), typically with a 63x C-Apochromat water immersion objective (aperture at 1.2) after loading with Fluo-4 (3 µM; excitation 488 nm, emission 505 nm) and tetramethyl rhodamine methyl ester (50 nM; excitation 543 nm, emission >550 nm) to assess cytosolic calcium and mitochondrial membrane potential, with simultaneous measurements of NAD(P)H autofluorescence (excitation 351 nm, emission 385–470 nm) to assess mitochondrial metabolism. The protonophore carbonyl cyanide m-chlorophenyl hydrazone (CCCP) was applied to dissipate Δψm as a positive control. ROS were assessed after loading with 5-chloromethyl-2,7-dichlorodihydrofluorescein diacetate acetyl ester (4.5 μM; excitation 488 nm, emission 505–550 nm) for 10 min at 37°C.12 R110-aspartic acid amide (20 μM; excitation 488 nm, emission >505 nm) and propidium iodide (PI 1 µM; excitation 488 nm, emission 630–693 nm) were used to assess general caspase activation and plasma membrane rupture. Thirty random fields of view were taken of each isolate and the percentage number of cells displaying caspase activity or PI uptake counted per field, averaged across fields as mean±SEM (minimum three mice/group). PI was used in patched cells (below), as was Mg Green (4 µM, excitation 476 nm, emission 500–550 nm), to monitor intracellular ATP concentrations.6 Murine pancreas lobules were incubated with/without 500 μM TLCS and stained with Sytox Orange24 (500 nM, excitation 543 nm, emission >560 nm), which like PI only stains cells with ruptured cell membranes: uptake was determined every two hours by % area tissue stained.
Patch-clamp current recording
The whole-cell configuration was used to record IClCa from single cells while recording cytosolic calcium (Fluo-4).25 Patch-pipettes were pulled from borosilicate glass capillaries (Harvard Apparatus) with resistance of 2–3 MΩ when filled with a solution of (mM): 140 KCl; 1.5 MgCl2; 2 MgATP; 10 HEPES; 0.1 ethylene glycol tetraacetic acid, pH 7.2. The second messenger IP3, cyclic ADP ribose (ADPR) or nicotinic acid adenine dinucleotide phosphate (NAADP) was added to the pipette solution at quasi-physiological concentrations (1–10 μM); in some experiments, MgATP was omitted, while in others MgATP was raised to 4 mM. Patched cells were exposed to TLCS (10 µM with second messenger or ACh or CCK-8, otherwise 200 µM) or palmitoleic acid ethyl ester (POAEE, 10 µM) for 20 min then stained with PI. Whole-cell currents were sampled at 10 kHz (EPS8 amplifier and Pulse software, HEKA) from a holding potential of −30 mV, with steps to +10 mV, beyond the reversal potential (0 mV) of the two Ca2+-dependent currents through Cl− and non-selective cationic channels.25
Caerulein (CER)-AP was induced in male (25–30 g) mice by 7 hourly intraperitoneal injections of 50 μg/kg CER;26 controls received saline; sacrifice was made 7 h after the first injection for Ppif−/− comparisons with Wt, or 12 h for assessment of DEB025 or TRO40303 in Wt. Dosing was determined by prior pharmacokinetic and pharmacodynamic studies (data not shown), which identified optimum regimens of 12 hourly injections of DEB025 at 10 mg/kg or TRO40303 at 3 mg/kg. TLCS-AP was induced as described27 by retrograde injection of the pancreatic duct with 3 mM TLCS while controls had ductal injection of saline; sacrifice was 24 h later. Fatty acid ethyl ester (FAEE)-AP was induced by 2 hourly intraperitoneal 1.35 g/kg ethanol and 150 mg/kg palmitoleic acid (POA)11 with controls receiving saline; sacrifice was 24 h later. Choline-deficient ethionine-supplemented (CDE)-AP was induced in young female mice (14–15 g) fasted overnight and fed CDE28 or regular chow for 48 h, then sacrificed.
Pancreatic necrosis was measured on H&E sections as described and apoptosis with TUNEL.7 Two independent, blinded investigators scored oedema, leucocyte infiltration and necrosis (0–3) on ×10 high-power fields/slide/mouse. Scores were summated (mean±SEM ≥6 mice/group; ≥4 for CDE-AP).
Data are presented as mean±SEM. Analysis was by two-tailed Student's t test or χ2 test, with p values <0.05 considered significant.
For preparation of pancreas tissue slices and lobules, measurement of isolated mitochondrial responses, electron microscopy, immunofluorescence, further assessment of disease parameters in experimental AP and details of chemicals and reagents, see online supplementary materials.
Pharmacological MPTP inhibition prevents pancreatitis toxin-induced mitochondrial impairment and necrotic cell death pathway activation
First, we tested the effect of known MPTP inhibitors on toxin-induced changes in pancreatic acinar cells using cyclosporin A (CYA), which binds to and inhibits cyclophilin D, or bongkrekic acid (BKA), which favours the closed conformation of adenine nucleotide translocase.29 We used murine cells hyperstimulated with CCK-818 ,30 to induce cytosolic and mitochondrial calcium overload,6 ,12 and found loss of Δψm7 ,18 causing decreases in NAD(P)H (figure 1A), reflecting declining ATP production.4 The bile acid TLCS31 induced similar changes (figure 1B). Both CYA and BKA prevented losses of Δψm and NAD(P)H. TLCS-induced mitochondrial impairment was completely prevented by the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid and was dose dependent (see online supplementary figure S1). We then tested D-MeAla3-EtVal4-cyclosporine (Alisporivir, DEB025), which inhibits cyclophilin D but is not immunosuppressive29 and 3,5-Seco-4-nor-cholestan-5-one oxime-3-ol (TRO40303), which also inhibits MPTP opening;32 both prevented decreases of Δψm in murine and freshly isolated human pancreatic acinar cells (figure 1C). Marked cell death pathway activation was induced by CCK-8 and TLCS; whereas caspase activation occurred in the presence of CYA or BKA, PI uptake was largely prevented (figure 1D). Marked protection from TLCS in human pancreatic acinar cells22 and human pancreas slices followed pretreatment with CYA, DEB025 and TRO40303 (figure 1E, F).
Genetic MPTP inhibition prevents pancreatitis toxin-induced mitochondrial impairment and necrotic cell death pathway activation
Cytosolic calcium changes were significantly less marked in pharmacologically treated than control cells (seen with CYA and BKA due to an initial release of calcium from cell stores, but not with DEB025 or TRO40303, see online supplementary figure S1), which might reduce mitochondrial calcium loading, so we examined effects of genetic deletion (Ppif−/−) of cyclophilin D.20 Comparison of Ppif−/− and Wt (C57BL/6) cells showed CCK-8-induced cytosolic calcium elevations were similar, but in Ppif−/− calcium clearance was significantly faster (mean±SE area under curve (F/F0×s) 199.61±26.45 vs 262.35±30.73 in Wt, p<0.05), a function of calcium ATPase pumps (figure 2A, left). In Wt cells, Δψm and NAD(P)H fell steadily, but not in Ppif−/− (figure 2A, middle and right). TLCS induced similar changes (figure 2B) with significantly faster calcium clearance in Ppif−/− cells (243.82±32.34 vs 378.92±45.98 in Wt, p<0.05), despite little difference detected in mitochondrial calcium loading (figure 2C, left). Subsequent experiments demonstrated no difference between Ppif−/− and Wt cells in store-operated calcium entry or plasma membrane ATPase calcium pump extrusion (see online supplementary figure S1), consistent with more effective ATP supply in Ppif−/− compared with Wt cells subjected to CCK-8- or TLCS-induced calcium overload. As TLCS-induced ROS increases promote apoptosis not necrosis of pancreatic acinar cells,12 ,23 we tested whether ROS increases are greater in Ppif−/− cells and found no differences from Wt (figure 2C, middle), ruling this out as a protective mechanism. Ethanol and POA, which form the toxic FAEE POAEE that induces AP,11 also caused marked falls of Δψm in Wt not Ppif−/− cells (figure 2C, right). There were marked effects of Ppif−/− on PI uptake but little on general caspase activation (figure 2D), consistent with a minor role for MPTP opening in pancreatic acinar cell apoptosis.7 ,23 In keeping, cytosolic cytochrome c release was seen in both Ppif−/− and Wt cells after hyperstimulation, although less in Ppif−/− cells (figure 2E). We also tested pancreatic lobules, more closely representing events in vivo, and found necrotic pathway activation (Sytox Orange uptake)24 markedly inhibited in Ppif−/− (figure 2F).
Pancreatitis toxin-induced acinar cell MPTP opening causes collapse of ATP production and necrotic cell death pathway activation via second messenger receptor calcium channel release
As bile acids and FAEEs induce global, prolonged acinar cytosolic calcium release via IP3R and RyR calcium channels,6 ,33 which causes zymogen activation34 ,35 dependent on sustained calcium entry,36 we sought to determine how toxin-induced calcium release causes mitochondrial injury and pancreatic acinar cell death. Using patch clamp technology and confocal microscopy, we observed typical apical stimulus-secretion coupling calcium signals elicited by IP3 (1–10 μM), matched by calcium-activated Cl− currents4 ,25 (IClCa). These signals were promptly transformed into global, prolonged (>30 s) cytosolic calcium elevations by low concentrations of TLCS (10 μM, 31 of 33 cells, figure 3A, B) or POAEE (10 μM, 34 of 37 cells, see online supplementary figure S2), followed by PI uptake in Wt cells (figure 3B and see online supplementary table). Application of the non-specific IP3R antagonist caffeine6 inhibited calcium changes and ICICa from both toxins, preventing PI uptake (22 of 22 cells, figure 3A, see online supplementary figure S2 and table), demonstrating dependence of toxic transformation on IP3Rs. Necrotic cell death pathway activation was entirely dependent on calcium influx (figure 3B and see online supplementary figure S2). Typical calcium signals and ICICa elicited by the RyR ligand cyclic ADPR (cyclic ADPR, 10 μM)25 were transformed by TLCS (10 μM), not POAEE; those elicited by NAADP (100 nM)25 were transformed by POAEE (10 μM), not TLCS (see online supplementary figure S2). To model events in vivo, quasi-physiological concentrations of CCK-8 or acetylcholine (ACh) were tested with both toxins, again resulting in toxic transformation (24 of 24 cells, no patch pipette, figure 3C, see online supplementary figure S2 and table). Without any second messenger or secretagogue, higher toxin concentrations (TLCS, 200 μM, figure 3D; POAEE 100 μM, data not shown; both inhibited by caffeine) were required to induce global, prolonged calcium elevations. All protocols that induced such elevations sustained by external calcium entry resulted in PI uptake in Wt cells (56 of 60 cells, ≥5 cells with each protocol; figure 3B–D); patched ATP resulted in more efficient calcium clearance and prevented all PI uptake (46 of 46 Wt cells, ≥4 cells with each protocol; p<0.0001), and ATP depletion from toxic transformation without patched ATP was confirmed using Mg Green (figure 3C, see online supplementary figure S2 and table). In all Ppif−/− cells, there was significantly more efficient calcium clearance, reduced ICICa and return to baseline levels with no PI uptake, despite no patched ATP (IP3 and TLCS, 10 μM, 17 of 17 cells; TLCS, 200 μM, 7 of 7 cells, figure 3D). These findings identify a primary role for second messenger calcium channel release in MPTP opening induced by pancreatitis toxins, resulting in declining ATP production and necrosis.
The MPTP determines the sensitivity of pancreatic mitochondria to calcium overload and PGAM5 induction
To confirm the role of calcium overload in pancreatic acinar cell MPTP opening, we examined responses of isolated Ppif−/− and Wt pancreatic mitochondria to external calcium. Ppif−/− and Wt pancreatic mitochondria demonstrated similar capacity to generate ATP, as measured by respiration rate in response to ADP (respiratory control ratio) >3 in the presence of succinate23 (figure 4A). Both types of mitochondria maintained Δψm in zero or 0.6 μM clamped, free ionised calcium for 10 min; in 1.3 µM calcium Wt Δψm collapsed, whereas Ppif−/− Δψm was maintained. While Wt Δψm was lost after one addition of 25 µM CaCl2, Ppif−/− Δψm was lost after five successive additions (figure 4B, C). Ppif−/− pancreatic mitochondria released only 35% less cytochrome c than Wt in 1.3 µM calcium (figure 4D), consistent with a modest contribution from MPTP opening to cytochrome c release. To further assess the significance of MPTP opening and falls in Δψm, we measured levels of PGAM5, a mitochondrial executor of necrosis.19 Falls in Δψm cause PGAM5 cleavage from the inner mitochondrial membrane,37 and increases in PGAM5 promote necrosis, facilitating mitochondrial fission.19 After induction of CER-AP, PGAM5 was increased in Wt but significantly less in Ppif−/− pancreata (figure 4E), indicating a mitochondrial mechanism for necrosis induced by calcium overload in AP. These changes were associated with marked ballooning of and loss of cristae in Wt but not Ppif−/− pancreatic acinar mitochondria in CER-AP (figure 4F).
The MPTP mediates zymogen activation through impaired autophagy
Since zymogen activation is considered essential to AP and relates to disease severity,1 ,38–40 we sought to determine whether and how this is MPTP dependent. We found CCK-8-induced trypsin activity significantly inhibited in Ppif−/− compared with Wt (figure 5A), despite no differences in the amount of trypsinogen (or amylase) between Wt and Ppif−/− mice pancreata (figure 5B; nor cathepsin B, Bcl-xL or Bcl-2, data not shown). This finding indicates that MPTP opening contributes to pathological, intra-acinar zymogen activation. Zymogen activation depends on intracellular calcium overload30 and accumulation of activated zymogens in AP is due to impaired autophagy.41 We therefore measured levels of microtubule-associated protein 1A/1B-light chain 3 (LC3), which in autophagy is converted from cytosolic LC3-I to lipidated LC3-II and recruited into autophagosomal membranes, and levels of sequestosome 1 (SQSTM1, p62), which sequesters ubiquitinated protein aggregates to autophagosomes; when autophagosomes fuse with lysosomes, both LC3-II and p62 are degraded.42 Following induction of CER-AP that features marked falls in ATP production, acinar cell vacuolisation and zymogen activation,7 ,38 ,43 significant increases in LC3-II and p62 occurred in Wt pancreata, showing retarded autophagy consistent with previous data.41 Increases in LC3-II and p62 were significantly attenuated in Ppif−/− mice (figure 5C–E), indicating more efficient autophagy.42 We confirmed the role of MPTP opening in defective autophagy using GFP LC3 mice,21 crossed with Ppif−/− mice. Analysis of LC3 puncta (autophagic vacuoles, figure 5F) as well as increases in LC3-II and p62 in GFP-LC3 versus GFP-LC3×Ppif−/− mice (≥3 mice/group, data not shown) confirmed significant attenuation from genetic inhibition of the MPTP.
Genetic or pharmacological MPTP inhibition sustains ATP production and confers striking protection from experimental AP
To determine comprehensively the significance of these mechanisms in vivo, we compared responses of Ppif−/− versus Wt mice in four dissimilar models of AP: CER-AP, TLCS pancreatic ductal infusion27 (TLCS-AP), ethanol with POA11 (FAEE-AP) and CDE-AP diet.28 These models represent the whole spectrum of human AP, including the commonest clinical aetiologies (gallstones and ethanol) and extending from mild to lethal disease. In all models, characteristic changes occurred in serum amylase and interleukin-6 (IL-6), pancreatic trypsin and myeloperoxidase, pancreatic ATP and histopathology (figures 6 and 7, see online supplementary figures S3 and S4). In contrast, all pathological responses were greatly inhibited in Ppif−/− animals, including lung myeloperoxidase and IL-6, which mediates lung injury and lethality.44 In Wt, DEB025 (10 mg/kg) or TRO40303 (3 mg/kg) administered 2 h after the start of hyperstimulation in CER-AP (figure 6C, D, see online supplementary figure S3) or 1 h after induction of TLCS-AP (figure 7) markedly reduced or abolished all pathological changes. Protection in TLCS-AP was close to complete: all changes in Ppif−/− mice or Wt (C57BL/6) mice treated with DEB025 or TRO40303 were no or minimally different from sham controls (figure 7). These findings demonstrate that inhibition of MPTP opening confers striking local and systemic protection from pancreatitis. The further new finding of relative independence of apoptotic processes from the MPTP (figure 6B) confirmed that apoptosis is not a major contributor to the pathological responses of AP,26 unless it is massive.45
This study demonstrates that MPTP opening is critical to experimental AP, mediating impaired ATP production, defective autophagy, zymogen activation, inflammatory responses and necrosis (figure 8), features of AP at molecular, cellular and whole organism levels.1 Our previous work identified metabolic effects of MPTP opening specific to ethanol. Here we have established the general significance of MPTP opening as a central mechanism in the pathogenesis of AP, and the primary role of calcium overload in this. The patch clamp data show how tight control of cytosolic calcium elevations essential to normal stimulus-secretion coupling by IP3Rs and RyRs4 is lost in Wt but maintained in Ppif−/− pancreatic acinar cells, which preserve ATP supply and clear calcium more effectively. Coupling of endoplasmic reticulum IP3Rs and RyRs with outer mitochondrial membranes tightly localises high calcium concentrations,46 but may expose mitochondria to abnormal calcium release, despite modulation by Bcl-2 family proteins.7 Here we have shown that pancreatitis toxins cause abnormal release of calcium via IP3Rs and RyRs that overloads pancreatic acinar mitochondria, which are markedly sensitive to calcium signals.23 The mitochondrial calcium overload induces high conductance MPTP opening and dissipates Δψm, initiating collapse of ATP production, diminished calcium clearance, PGAM5 activation and subsequent necrosis. Importantly for a disease without specific treatment, pharmacological MPTP inhibition29 ,47 administered after AP induction came close to preventing all injury, notably in the clinically relevant TLCS-AP.
For more than a century following an original postulate by Chiari,48 pancreatitis has been viewed as an autodigestive disease consequent on pathological zymogen activation.3 ,34 ,38 ,39 ,45 In experimental AP, zymogens are activated inside acinar cells within minutes of toxin exposure,1 ,3 ,30 ,41 which this work has shown to result from induction of the MPTP, caused by and contributing to calcium overload. Sustained calcium overload may activate degradative calpains, phospholipases or other enzymes17 and damage zymogen granules, inducing autophagic41 and/or endolysosomal49 responses that activate digestive enzymes. Such activation was not completely prevented by MPTP inhibition, however, likely from global cytosolic calcium overload that was seen to be more effectively cleared in Ppif−/− cells, without which overload no enzyme activation occurs.30 Nevertheless, intracellular expression of trypsin per se without mitochondrial injury leads to apoptotic not necrotic pathway activation45 and trypsinogen activation does not appear necessary for either local or systemic inflammation;50 knockout of cathepsin B greatly reduces trypsinogen activation with little effect on serum IL-6 or lung injury.39 Hereditary pancreatitis caused by cationic trypsinogen gene mutations rarely features clinically significant pancreatic necrosis;51 ,52 further, systemic protease inhibition has had little success as a clinical strategy,1 suggesting that while zymogen activation contributes, it is not the critical driver of AP. This study, however, shows that MPTP opening triggers defective autophagy, while inhibition of MPTP opening preserved ATP supply, increased the efficiency of autophagy and decreased zymogen activation. Together with major effects of MPTP opening on PGAM5 activation that implements necrosis,19 ,37 and on local and systemic inflammatory responses, these findings now place mitochondrial injury centrally in AP.
Our new data show that in pancreatic acinar cells IP3Rs and RyRs are vulnerable to specific toxins that markedly increase their calcium channel open-state probabilities. Toxic transformation of calcium channel function induced pancreatic acinar cell necrosis through calcium-dependent formation of the MPTP, with diminished ATP production the critical consequence. Toxic transformation by different toxins was specific to different second messengers, identifying potential for a variety of deleterious effects. ATP deficiency may be further exacerbated by fatty acids released on hydrolysis of FAEEs or triglycerides,53 which may inhibit beta oxidation.6 Without sufficient ATP, cytosolic calcium overload produces a vicious circle in which high-affinity, low-capacity sarcoendoplasmic reticulum calcium transport ATPase (SERCA) and plasma membrane calcium ATPase (PMCA) pump clearance of cytosolic calcium is impaired, further mitochondrial injury sustained and necrotic cell death accelerated.6 ,12 Although the toxicity of cytosolic calcium overload depends on calcium store refilling from outside the cell,30 ,54 specific second messenger receptor blockade demonstrated calcium overload to be due completely to release from their calcium channels, not direct effects of toxins on calcium entry or extrusion.
Whereas the vast majority of previous studies undertaken to determine mechanisms and/or new targets in AP have used only one model, our four models are broadly representative of a range of aetiologies, including biliary (TLCS-AP), hyperstimulation (CER-AP), ethanolic (FAEE-AP) and amino acid-induced (CDE-AP).1 ,55 Our findings in experimental AP are entirely consistent with those made in isolated mitochondria and cells, identifying a generalised mechanism of pancreatic injury and necrosis, confirmed in murine and human pancreatic acinar cells, pancreas lobules and tissue slices. Pancreatic necrosis drives the inflammasome,56 which can be induced by MPTP opening57 and is part of the systemic inflammatory response contributing to multiple organ failure.2 Further pancreatic injury is driven through tumour necrosis factor receptor activation that also promotes MPTP opening58 and calcium deregulation, activating calcineurin and NFAT.59 Our data link necrosis and inflammation directly, highlighting the potential of the MPTP as a drug target for AP.
The authors thank Dr George Perides and Professor Michael Steer who taught R.M. techniques for TLCS-AP.
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Collaborators The authors are indebted to members of the NIHR Pancreas BRU: Diane Latawiec for technical assistance, Dayani Rajamanoharan for pancreatic lobule assays, Euan Mclaughlin for whole cell assays with caffeine and Paula Ghaneh, Christopher Halloran, John P Neoptolemos and Michael GT Raraty for provision of human pancreas tissue samples. The authors wish to thank Dr Samuel W. French (Harbor-UCLA Medical Center, Torrance, CA) for providing electron micrographs that show mitochondrial damage in CER-AP.
Contributors RM and OAM are co-first authors. ASG and RS are co-senior authors. ASG and RS designed and supervised the study. RM, OAM, IVO, WH, JM, MC, MAJ, LW, DMB, MCC and MA performed the experiments. BG, RMP, SS, AVT, OHP, SJP, IG, JDM, DNC and the NIHR Pancreas BRU made technical and scientific contributions. RS, ASG, IG, RM and OAM wrote the paper.
Funding This work was supported by US Veterans Administration Merit Review (ASG), NIH grants R01DK59936 (ASG) and R01AA19730 (IG and OAM), Southern California Research Center for Alcoholic Liver and Pancreatic Diseases (SJP and ASG), American Gastroenterological Association Foundation Designated Research Scholar Award in Pancreatitis (OAM), Russian Federation BR grant 09-04-00739 (IVO), UK/China Postgraduate Research Scholarship for Excellence (WH), Liverpool China Scholarship Council Award (LW), CORE, UK (RM, JM, MAJ), UK Medical Research Council (DMB, MC, MCC, OHP, AVT, DNC and RS), Royal College of Surgeons of England (MAJ) and UK NIHR Biomedical Research Unit Funding Scheme (MA, AVT, DNC and RS).
Competing interests BG is an employee of Debiopharm Research and Manufacturing S.A., who supplied DEB025; RMP and SS are employees of Trophos SA, who supplied TRO40303; RS has received research funding from Debiopharm Research and Manufacturing S.A. and has acted as a consultant for Novartis International A.G.
Ethics approval Human pancreatic samples were donated by patients undergoing surgery for left-sided or unobstructing pancreatic tumours as approved by Liverpool Adult Local Research Ethics Committee (Ref: 03/12/242/A). Animal protocols were approved by UK Home Office (PPL 40/3320) and animal research committee of Veterans Affairs Greater Los Angeles Healthcare System, as per NIH guidelines..
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement Further unpublished data identified in the text of this article can be made available to bona fide researchers after communication with the corresponding author.